FBI Suspects Tea Company that ‘Pivoted’ to Blockchain of Insider Trading (TheNextWeb.com)
Long Island Tea Corp was one of those companies that randomly added the word “blockchain” to the name of their business to seem cool (and maybe bump up its stock) – but it appears its name change may be more sinister than first thought. The Federal Bureau of Investigation suspects Long Blockchain Corp., as it is now known, may be guilty of insider trading, Quartz reports. According to a request for a search warrant, the FBI is also searching for evidence of securities fraud.
Friday 7/26 Insider Buying Report: CCI, EIC (Nasdaq.com)
At Crown Castle International Corp (CCI), a filing with the SEC revealed that on Tuesday, Director J. Landis Martin bought 16,300 shares of CCI, at a cost of $127.33 each, for a total investment of $2.08M. So far Martin is in the green, up about 2.6% on their buy based on today’s trading high of $130.67. Crown Castle International Corp is trading up about 0.2% on the day Friday. Before this latest buy, Martin purchased CCI at 2 other times during the past year, for a total investment of $3.35M at an average of $118.58 per share. And at Eagle Point Income Company (EIC), there was insider buying on Wednesday, by CEO Thomas P. Majewski who bought 10,100 shares for a cost of $19.89 each, for a total investment of $200,889. This buy marks the first one filed by Majewski in the past twelve months.
Insiders Roundup: Garmin, Best Buy (Guru Focus)
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “July 2019” and All Insider Sales to “$200,000+.” According to these filters, the following are trades from company insiders last week. Director Jeffrey W. Bird and 10% owner Lightspeed Venture Partners X bought a combined 1,375,000 shares of Forty Seven Inc. (FTSV) for an average price of $8 per share on July 22.
Insider Activity: Large Investor in Esperion Therapeutics (ESPR) Buys $2.1 Million in Stock (Investors Observer)
Biotech Target N V, who already control 10% of shares at Esperion Therapeutics (ESPR), bought 50,000 additional shares of the company’s common stock on Jul 23. At $42.65 per share, Biotech Target N V paid a total of $2,123,565 for the new shares.
The SVP HR of Danaher Corp is Exercising Options (Analyst Ratings)
Today it was reported that the SVP HR of Danaher Corp (DHR), Angela Lalor, exercised options to sell 20,000 DHR shares at $46.13 a share, for a total transaction value of $2.85M. Following Angela Lalor’s last DHR Sell transaction on May 20, 2019, the stock climbed by 12.5%. In addition to Angela Lalor, 2 other DHR executives reported Sell trades in the last month.
Two Former Traders Admit To Engaging in Spoofing and Manipulation at New York Banks (HedgeCo.net)
(HedgeCo.Net) The U.S. Commodity Futures Trading Commission has issued two orders filing and settling charges against former traders at separate financial institutions who entered into formal cooperation agreements with the CFTC’s Division of Enforcement (Division) and admitted to spoofing and manipulative conduct in the futures markets. James McDonald, the Director of Enforcement, commented: “Today’s enforcement actions send a clear message that spoofing and manipulation in our markets will not be tolerated and that the CFTC will use all of the tools in its arsenal to aggressively pursue individuals and entities who engage in this misconduct. These cases also show that, where an individual has demonstrated a commitment to cooperate, and has cooperated, the CFTC may elect to postpone the assessment of the cooperator’s sanctions until the cooperation is substantially complete.”
